eesti teaduste
akadeemia kirjastus
SINCE 1952
Proceeding cover
of the estonian academy of sciences
ISSN 1736-7530 (Electronic)
ISSN 1736-6046 (Print)
Impact Factor (2020): 1.045

Potassium iodide catalysis in the alkylation of protected hydrazines; pp. 10–17

Full article in PDF format |

Anton Mastitski, Aleksander Abramov, Anneli Kruve, Jaak Järv


Potassium iodide catalysis was applied for the synthesis of protected benzylhydrazines and hydrazinoacetic acid esters by the alkylation of protected hydrazines. Benzylic halogenides and halogenoacetic acid esters were employed as alkylating agents. In these syntheses the reactive alkyl iodide molecules were generated in situ from less reactive halogenides, which significantly accelerated the alkylation reaction. The effectiveness of potassium iodide catalysis was proved by experiments performed under the same conditions in the absence of this salt.


     1.           Boeglin, D. and Lubell, W. D. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with Fmoc chemistry and aza-amino acids with heteroatomic side chains. J. Comb. Chem., 2005, 7, 864–878.

    2.           Quibell, M., Turnell, W. G., and Johnson, T. Synthesis of azapeptides by the Fmoc/tert-butyl/polyamide technique. J. Chem. Soc., Perkin Trans. 1, 1993, 2843–2849.

    3.           Zega, A. Azapeptides as pharmacological agents. Curr. Med. Chem., 2005, 12, 589–597.

    4.           Proulx, C., Sabatino, D., Hopewell, R., Spiegel, J., Garcia Ramos, Y., and Lubell, W. D. Azapeptides and their therapeutic potential. Future Med. Chem., 2011, 3, 1139–1164.

    5.           Fässler, A., Bold, G., Capraro, H.-G., Cozens, R., Mestan, J., Poncioni, B., et al. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability. J. Med. Chem., 1996, 39, 3203–3216.

    6.           Venkatraman, S., Wu, W., Shih, N.-Y., and Njoroge, F. G. Potent aza-peptide derived inhibitors of HCV NS3 protease. Bioorg. Med. Chem. Lett., 2009, 19, 4760–4763.

    7.           Staal, E. and Faurholt, C. Carbamates. IV. The carbamate of hydrazine. Dansk Tidsskrift for Farmaci, 1951, 25, 112.

    8.           Mastitski, A., Kisseljova, K., and Järv, J. Synthesis of the Fmoc-aza-Arg(Boc)2 precursor via hydrazine alkylation. Proc. Estonian Acad. Sci., 2014, 63, 438–443.

    9.           Mastitski, A., Haljasorg, T., Kipper, K., and Järv, J. Synthesis of aza-phenylalanine, aza-tyrosine, and aza-tryptophan precursors via hydrazine alkylation. Proc. Estonian. Acad. Sci., 2015, 64, 168–178.

 10.           Busnel, O., Bi, L., Dali, H., Cheguillaume, A., Chevance, S., Bondon, A., et al. Solid-phase synthesis of “mixed” peptidomimetics using Fmoc-protected aza-β3-amino acids and α-amino acids. J. Org. Chem., 2005, 70, 10701–10708.

 11.           Busnel, O. and Baudy-Floc’h, M. Preparation of new monomers aza-β3-aminoacids for solid-phase syntheses of aza-β3-peptides. Tetrahedron Lett., 2007, 48, 5767–5770.

 12.           Ruan, M., Nicolas, I., and Baudy-Floc’h, M. New building blocks or dendritic pseudopeptides for metal chelating. SpringerPlus, 2016, 5, 55.

 13.           Ragnarsson, U. Synthetic methodology for alkyl sub­stituted hydrazines. Chem. Soc. Rev., 2001, 30, 205–213.

 14.           Lee, J. and Bogyo, M. Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain. ACS Chem. Biol., 2010, 5, 233–243.

 15.           Spiegel, J., Mas-Moruno, C., Kessler, H., and Lubell, W. D. Cyclic aza-peptide integrin ligand synthesis and bio­logical activity. J. Org. Chem., 2012, 77, 5271–5278.

 16.           Zouikri, M., Vicherat, A., Marraud, M., and Boussar, G. Azaproline as a beta-turn-inducer residue opposed to proline. J. Pept. Res., 1998, 52, 19–26.

 17.           Garcia-Ramos, Y., Proulx, C., and Lubell, W. D. Synthesis of hydrazine and azapeptide derivatives by alkylation of carbazates and semicarbazones. Can. J. Chem., 2012, 90, 11, 985–993.

 18.           Traoré, M., Doan, N. D., and Lubell, W. D. Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine. Org. Lett., 2014, 16, 3588–3591.

 19.           Douchez, A. and Lubell, W. D. Chemoselective alkylation for diversity-oriented synthesis of 1,3,4-benzotriazepin-2-ones and pyrrolo[1,2][1,3,4]benzotriazepin-6-ones, potential turn surrogates. Org. Lett., 2015, 17, 6046–6049.

 20.           Doan, N.-D., Zhang, J., Traoré, M., Kamdem, W., and Lubell, W. D. Solid-phase synthesis of C-terminal azapeptides. J. Pept. Sci., 2015, 21, 387–391.

 21.           Merlino, F., Yousif, A. M., Billard, E., Dufour-Gallant, J., Turcotte, S., Grieco, P., et al. Urotensin II(4–11) azasulfuryl peptides: synthesis and biological activity. J. Med. Chem., 2016, 59, 4740−4752.

 22.           Romera, J. L., Cid, J. M., and Trabanco, A. A. Potassium iodide catalyzed monoalkylation of anilines under microwave irradiation. Tetrahedron Lett., 2004, 45, 8797–8800.

 23.           Kabalka, G. W., Reddy, N. K., and Narayana, C. Lithium iodide-catalyzed alkylation of carboranes. Tetrahedron Lett., 1992, 33, 7687–7688.

 24.           Satoh, T., Matsue, R., Fujii, T., and Morikawa, S. Alkylation of nonstabilized aziridinylmagnesiums catalyzed by Cu(I) iodide: a new synthesis of amines, including optically active form, bearing a quaternary chiral center. Tetrahedron Lett., 2000, 41, 6495–6499.

 25.           Carpino, L. A. and Han, G. Y. The 9-fluorenylmethoxy­carbonyl amino-protecting group. J. Org. Chem., 1972, 37, 3404–3409.

 26.           Rabjohn, N. The synthesis and reactions of disazodi­carboxylates. J. Am. Chem. Soc., 1948, 70, 1181–1183.

 27.           McKay, F. C. and Albertson, N. F. New amine-masking groups for peptide synthesis. J. Am. Chem. Soc., 1957, 79, 4686–4690.

 28.           Dourlat, J., Liu, W.-Q., Gresh, N., and Garbay, C. Novel 1,4-benzodiazepine derivatives with antiproliferative properties on tumor cell lines. Biorg. Med. Chem. Lett., 2007, 17, 2527–2530.

 29.           Mäeorg, U., Pehk, T., and Ragnarsson, U. Synthesis of substituted hydrazines from triprotected precursors. Acta Chem. Scan., 1999, 53, 1127–1133.

 30.           Carpino, L. A., Santilli, A. A., and Murray, R. W. Oxidative reactions of hydrazines. V. Synthesis of monobenzyl 1,1-disubstituted hydrazines and 2-amino-2,3-dihydro-1H-benz[de]isoquinoline. J. Am. Chem. Soc., 1960, 82, 2728–2731.

 31.           Gwaltney, S. L., O’Connor, S. J., Nelson, L. T. J., Sullivan, G. M., Imade, H., Wang, W., et al. Aryl tetrahydro­pyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency. Bioorg. Med. Chem. Lett., 2003, 13, 1363–1366.

 32.           Bouayad-Gervais, S. H. and Lubell, W. D. Examination of the potential for adaptive chirality of the nitrogen chiral center in aza-aspartame. Molecules, 2013, 18, 14739–14746.

 33.           Squibb, E. R. and Sons, Inc. Preparation of N-Sub­stituted Azetidinone Derivatives as Antibiotics. Belgian patent BE 905 205; Chem. Abstr., 1988, 108, 693, 55 763e.

 34.           Peifer, M., Giacomo, F. D., Schandl, M., and Vasella, A. Oligonucleotide analogues with integrated bases and backbone hydrazide- and amide-linked analogues. 1. Design and synthesis of monomeric building blocks. Helv. Chim. Acta, 2009, 92, 1134–1166.

Hartmut, N. Hydrazinverbindungen als Heterobestandteile in Peptiden. VI. Weitere Derivate der Hydra­zinoessigsäure und ihre Verwendung zur Synthese von Hydrazino- und N-Amino-peptiden. Chem. Ber., 1965, 98, 3451–3461.

Back to Issue